CRISIL Ltd. — Capital/Financing Update 2024

Oct 16, 2024

==> picture [596 x 83] intentionally omitted <==

October 16, 2024

Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, 5[th] floor P J Towers Plot No. C/1, G Block Dalal Street Bandra-Kurla Complex Mumbai 400 001 Bandra (East), Mumbai 400 051

Dear Sir

Sub.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”)

The Board of Directors of Peter Lee Associates Pty Ltd (“PLA”) and CRISIL Irevna Australia Pty Ltd (“CRISIL Australia”), the two wholly owned subsidiaries of the Company based in Australia, have approved sale of business of PLA to CRISIL Australia through a Business Transfer Agreement. This will be followed by a deregistration of PLA. This will mean the operation of only one subsidiary in Australia.

The details as required under SEBI Listing Regulations read with clause (1) of Para A of Part A of Schedule III of the SEBI Listing Regulations and the SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023, are enclosed as Annexure ‘A’.

Kindly take this communication on record and inform your members accordingly.

Yours faithfully,

For CRISIL Limited

MINAL Digitally signed by MINAL AMIT AMIT BHOSALE Date: 2024.10.16 BHOSALE 19:01:14 +05'30'

Minal Bhosale Company Secretary ACS 12999

Encl.: a/a

CRISIL Limited

Corporate Identity Number: L67120MH1987PLC042363

Registered Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400076. Phone: +91 22 3342 3000 | Fax: +91 22 3342 3001 www.crisil.com

Annexure A

Details and reasons for restructuring		The Board of Directors of Peter Lee Associates Pty Ltd (“PLA”) and CRISIL Irevna Australia Pty Ltd (“CRISIL Australia”), the two wholly owned subsidiaries of the Company based in Australia, have approved sale of business of PLA to CRISIL Australia through a Business Transfer Agreement. This will be followed by a deregistration of PLA. This will mean the operation of only one subsidiary in Australia.
Quantitative effect of restructuring		CRISIL Australia will pay a cash consideration equivalent to the Net Asset Value of the business of PLA as on the Completion Date of transfer.
Qualitative effect of restructuring		Streamlining CRISIL's global entity structure
Details of benefit, if any, to the promoter/promoter group/group companies from such proposed restructuring		Nil
Whether the promoter / promoter group/ group/ associate/ holding/ subsidiary companies/ Director & KMP and its relatives have any interest in the entity being acquired?		No
Brief Details of change in shareholding pattern (if any) of all entities		There will be no change to the shareholding pattern of CRISIL.
Any other significant information (in brief) – Entity details		Turnover CRISIL Australia and PLA, both are wholly owned subsidiaries of CRISIL Limited (Amt in AUD) Particulars (FY 2023) CRISIL Australia PLA Standalone Turnover 937,292 2,487,736 Area of the business CRISIL Australia provides research, quantitative and risk solutions. PLA is into research and consulting, providing benchmarking research programs to the financial services sector.

CRISIL Limited

Corporate Identity Number: L67120MH1987PLC042363

Registered Office: CRISIL House, Central Avenue, Hiranandani Business Park, Powai, Mumbai - 400076. Phone: +91 22 3342 3000 | Fax: +91 22 3342 3001 www.crisil.com